indomethacin has been researched along with Spina Bifida Aperta in 1 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The association of DA constriction and low BMI suggests that BMI-based dosing of indomethacin may be recommended for perioperative tocolysis in fetal MMC surgery." | 1.56 | Maternal low body mass index is a risk factor for fetal ductal constriction following indomethacin use among women undergoing fetal repair of spina bifida. ( Belfort, MA; Cortes, MS; Donado, MY; Erfani, H; Espinoza, J; Furtun, BY; Nassr, AA; Olutoye, O; Shamshirsaz, AA; Velez, MP; Whitehead, WE, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nassr, AA | 1 |
| Furtun, BY | 1 |
| Cortes, MS | 1 |
| Erfani, H | 1 |
| Whitehead, WE | 1 |
| Donado, MY | 1 |
| Olutoye, O | 1 |
| Velez, MP | 1 |
| Espinoza, J | 1 |
| Belfort, MA | 1 |
| Shamshirsaz, AA | 1 |
1 other study available for indomethacin and Spina Bifida Aperta
| Article | Year |
|---|---|
Maternal low body mass index is a risk factor for fetal ductal constriction following indomethacin use among women undergoing fetal repair of spina bifida.
Topics: Adult; Body Mass Index; Cohort Studies; Constriction, Pathologic; Cyclooxygenase Inhibitors; Ductus | 2020 |